Voltaren and Truvada drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Voltaren (diclofenac sodium) and Truvada (emtricitabine; tenofovir disoproxil fumarate). Common drug interactions include amylase increased among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Voltaren and Truvada. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Truvada?

Truvada has active ingredients of emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 76,246 Truvada users. Check the latest studies of Truvada.



On Jul, 16, 2026

78 people who take Voltaren and Truvada together, and have interactions are studied.

Voltaren and Truvada drug interactions.

What are the common drug interactions of Voltaren and Truvada, by gender? *:

female:

  1. Amylase increased
  2. Cholangitis (infection of the bile duct)
  3. Hepatic enzyme increased
  4. Pancreatitis acute (sudden inflammation of pancreas)
  5. Cachexia (loss of weight)
  6. Cd4 lymphocytes decreased
  7. Infection
  8. Nausea (feeling of having an urge to vomit)
  9. Pyrexia (fever)
  10. Renal impairment (severely reduced kidney function)

male:

  1. Emotional distress
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Hyperaesthesia
  4. Fatigue (feeling of tiredness)
  5. Foot fracture
  6. Mobility decreased (ability to move is reduced)
  7. Drug abuse
  8. Asthenia (weakness)
  9. Hyperphosphaturia (excess of phosphates in the urine)
  10. Osteonecrosis (death of bone)

What are the common drug interactions of Voltaren and Truvada, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cellulitis (infection under the skin)
  2. Erythema (redness of the skin)
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Injury
  5. Lymphoedema (localized fluid retention and tissue swelling)
  6. Pain in extremity
  7. Premature baby
  8. Respiratory distress (difficulty in breathing)
  9. Tenderness (pain or discomfort when an affected area is touched)

20-29:

  1. Cachexia (loss of weight)
  2. Cd4 lymphocytes decreased
  3. Infection
  4. Nausea (feeling of having an urge to vomit)
  5. Pyrexia (fever)
  6. Renal failure (kidney dysfunction)
  7. Urine output decreased

30-39:

  1. Disease recurrence
  2. Abasia (inability to walk)
  3. Anal cancer
  4. Asthenia (weakness)
  5. Bone density decreased
  6. Chest pain
  7. Depressed mood
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  9. Erectile dysfunction
  10. Fatigue (feeling of tiredness)

40-49:

  1. Memory impairment
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Pneumonia
  4. Decreased activity
  5. Depression
  6. Fatigue (feeling of tiredness)
  7. Insomnia (sleeplessness)
  8. Osteonecrosis (death of bone)
  9. Panic attack
  10. Quality of life decreased

50-59:

  1. Emotional distress
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Chronic kidney disease
  5. Bone density decreased
  6. Multiple fractures
  7. Allodynia (a condition in which pain is caused by a stimulus that does not normally elicit pain)
  8. Hyperaesthesia
  9. Mobility decreased (ability to move is reduced)
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Osteoporosis (bones weak and more likely to break)
  2. Emotional distress
  3. Foot fracture
  4. Hip fracture
  5. Multiple fractures
  6. Tooth loss
  7. Arthropathy
  8. Gait disturbance
  9. Hepatic steatosis (fatty liver disease)
  10. Chronic kidney disease

What are the existing conditions these people have? *

  1. Pain: 13 people, 16.67%
  2. High Blood Pressure: 9 people, 11.54%
  3. Osteoporosis (bones weak and more likely to break): 7 people, 8.97%
  4. Depression: 7 people, 8.97%
  5. Stress And Anxiety: 6 people, 7.69%
  6. Hypersensitivity: 6 people, 7.69%
  7. Joint Pain: 5 people, 6.41%
  8. High Blood Cholesterol: 5 people, 6.41%
  9. Bipolar Disorder (mood disorder): 5 people, 6.41%
  10. Nausea (feeling of having an urge to vomit): 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and Truvada?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Voltaren and Truvada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Truvada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Voltaren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Truvada and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium and emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Voltaren and Truvada, respectively), and Voltaren and Truvada (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: